FISPB
VRTX icon

Fideuram - Intesa Sanpaolo Private Banking’s Vertex Pharmaceuticals VRTX Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.2M Buy
38,752
+3,761
+11% +$1.67M 0.58% 40
2026
Q1 		$15.6M Buy
34,991
+3,710
+12% +$1.73M 0.55% 43
2025
Q4 		$14.2M Buy
+31,281
New +$13.5M 0.51% 49

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's VRTX Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking increased its Vertex Pharmaceuticals (VRTX) stake by 11% in Q2 2026, buying an estimated $1.67M and bringing the position to 38,752 shares worth $19.2M. The position accounts for 0.58% of the portfolio, ranked #40.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 38,752 shares of Vertex Pharmaceuticals worth $19.2M as of Q2 2026.
  • Fideuram - Intesa Sanpaolo Private Banking bought 3,761 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.67M.
  • Vertex Pharmaceuticals made up 0.58% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #40 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.